NCT02000102View on ClinicalTrials.gov

Outcomes of Diabetic Macula Edema Patients Switched to Aflibercept From Bevacizumab and/or Ranibizumab

CompletedOBSERVATIONAL
Enrollment

14

Participants

Timeline

Start Date

September 30, 2013

Primary Completion Date

September 30, 2014

Study Completion Date

September 30, 2014

Conditions
Diabetic Macular Edema
Interventions
DRUG

Intravitreal Injection of Aflibercept

Trial Locations (1)

94303

Byers Eye Institute at Stanford, Palo Alto

All Listed Sponsors
lead

Stanford University

OTHER

NCT02000102 - Outcomes of Diabetic Macula Edema Patients Switched to Aflibercept From Bevacizumab and/or Ranibizumab | Biotech Hunter | Biotech Hunter